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Abstract The role of the C-terminal region of the 74-kDa form
of L-histidine decarboxylase (HDC) in the targeting to the
endoplasmic reticulum (ER) was investigated in COS-7 cells.
The deletion of a 10-kDa segment (residues 578^662) of the C-
terminal end of HDC, especially a 20 amino acid sequence
(residues 588^607), abrogated the targeting to the ER. The C-
terminal 10-kDa portion is sufficient to target the green
fluorescent protein (GFP) to the ER. The 74-kDa form of
HDC synthesized in an in vitro translation system post-
translationally associated with the heterogeneous canine micro-
somal membranes. These results suggest that the C-terminal 10-
kDa portion of HDC contains a signal necessary for HDC to be
targeted to the ER membrane.
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1. Introduction
The transfer of newly synthesized peptides to the endoplas-
mic reticulum (ER) is generally controlled by the signal rec-
ognition particle (SRP)/SRP receptor system [1^3], but an
alternative pathway controlled by the insertion sequence at
the C-terminal hydrophobic domain is recently reported [4^
7], although its mechanism is still unclear.
L-Histidine decarboxylase (HDC; EC 4.1.1.22) is a dimer
consisting of two identical 53^55-kDa subunits [8^11], while
the size of cDNA-deduced HDC is around 74 kDa [12^14].
We previously showed that the 74-kDa form expressed in Sf9
cells was recovered in the 100 000Ug precipitate fraction,
while the mutant 54-kDa form that lacks the C-terminal re-
gion of the 74-kDa form preferentially was recovered in the
supernatant fraction [15,16]. Furthermore, in rat basophilic
leukemia cell line, RBL-2H3 cells, the endogenous 74-kDa
form of HDC was translated in the cytosol and then trans-
located to the ER, where it was post-translationally processed
to the 53-kDa form [17]. In this cell line, the 74-kDa form in
the cytosol was demonstrated to be rapidly degraded by ATP/
ubiquitin-dependent proteosome system [18]. These results in-
dicate that the 74-kDa HDC, which is translated in the cyto-
sol, is targeted to the ER membranes. However, the 74-kDa
HDC has no N-terminal signal sequence and no hydrophobic
domain at the C-terminal region [14]. Therefore it is assumed
that this protein is inserted into the ER membrane without the
participation of the SRP/SRP receptor or the C-terminal an-
chor domain-dependent system. The present paper describes
the sequence at the C-terminal region responsible for the tar-
geting of the 74-kDa HDC to the ER membrane.
2. Materials and methods
2.1. Materials
Anti-GST-fusion HDC antiserum was prepared as described previ-
ously [19]. COS-7 cells were grown in Dulbecco’s modi¢ed Eagle
medium (DMEM) supplemented with 10% fetal calf serum.
2.2. Construction of expression vector
The partial amino acid sequence of the carboxyl-terminal 10-kDa
region deduced from the nucleotide sequence of HDC cDNA [14] is
shown in Fig. 1. Plasmids, pcDNA3/HDC5, pcDNA3/HDC6 and
pcDNA3/HDC7 were generated by subcloning EcoRI fragments of
vHDC5, vHDC6 and pVLHDC1 [15] into EcoRI site of pcDNA3
(Invitrogen, Carlsbad, CA, USA), respectively. The 3P-deletion mu-
tants of HDC cDNA were generated using PCR ampli¢cation with
Vent DNA polymerase (New England Biolabs, Beverly, MA, USA)
and the appropriate primers containing an EcoRI site and a stop
codon. All the plasmids were constructed by inserting EcoRI frag-
ments of the PCR products into the EcoRI site of pcDNA3. The
constructed vectors were named based on the numbering of the amino
acid residues mutated to the stop codon (Fig. 1). To produce the
green £uorescent protein (GFP)-fusion vectors, various C-terminal
segments of HDC were ampli¢ed by PCR using oligonucleotides com-
plementary to the 5P- and 3P-ends of the desired fragment. The oligo-
nucleotides had EcoRI sites at their 5P-end to facilitate cloning into
the expression vector, pEGFP-C1 (Clontech Laboratories, Palo Alto,
CA, USA).
2.3. Transient expression
COS-7 cells were transfected with the various constructs using a
CellPhect Transfection Kit (Pharmacia Biotech) according to the
manufacturer’s instructions. The cells were harvested 48 h after trans-
fection and assayed for expression of HDC activity and HDC protein.
2.4. Subcellular fractionation
Cells transfected with the various vectors were homogenized in
10 mM potassium phosphate, pH 6.8, containing 1.5 mM MgCl2,
FEBS 20954 20-10-98 Cyaan Magenta Geel Zwart
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 1 9 5 - 8
Fig. 1. Carboxyl-terminal sequence of HDC. The carboxyl-terminal
region of HDC is represented with one-letter codes for amino acids.
The mutated amino acid residues in the mutant HDCs numbered
relative to the stop codon are indicated by arrows.
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10 mM KCl, 0.2 mM DTT, 0.01 mM pyridoxal 5P-phosphate, 1 mM
EDTA, 1 mM EGTA, 0.2 mM PMSF, 10 Wg/ml leupeptin, 1 Wg/ml
pepstatin A, 10 Wg/ml E-64, 0.1 mM benzamidine and 10 Wg/ml apro-
tinin with a Te£on-glass homogenizer. The homogenate was centri-
fuged at 100 000Ug for 1 h at 4‡C to obtain the supernatant fraction
and the particulate fraction.
2.5. Immunoblot analysis
Immunoblot analysis and immuno£uorescence observation were
performed according to the procedures described in a previous paper
[17].
2.6. In vitro transcription and translation
Both pBSHDC5 and pBSHDC7 were linealized with SalI, and in
vitro RNA was transcribed using T7 RNA polymerase (Toyobo, Osa-
ka, Japan). In vitro translations were performed using a rabbit retic-
ulocyte lysate (Amersham, Buckinghamshire, England) according to
the manufacturer’s instructions. The translations were performed in a
volume of 20 Wl, with 10 Wl of rabbit reticulocyte lysate, 1 Wl of 2.5 M
potassium acetate, 0.5 Wl of 25 mM magnesium acetate, 2 Wl of 10U
translation mixture, 1 Wl of RNA (1 Wg/Wl), 20 WCi of [35S]methionine
(1000 Ci/mmol) (Du Pont-New England Nuclear, Boston, MA, USA)
and ribonuclease-free H2O at 30‡C for 80 min. Commercially pre-
pared canine microsomal membranes (Promega, Madison, WI,
USA) were added at the beginning (0.5 Wl) or after (4 Wl) the trans-
lation by adding 1 Wl of 1 mM cycloheximide.
2.7. Assay for the post-translational targeting of HDC protein
In vitro translation mixtures (21 Wl) prepared as described above
were incubated at 30‡C for 90 min with or without 4 Wl of canine
pancreatic microsomal membranes. To separate the microsomal mem-
branes, 10 Wl of rat microsomal membranes (5 mg protein/ml) and 35
Wl of 0.2 M Na2CO3 were added to the reaction mixtures (25 Wl)
which were incubated at 4‡C for 30 min. The mixtures were added
to 125 Wl of 2.5 M sucrose, and then 400 Wl of 1.25 M sucrose con-
taining 0.1 M Na2CO3 and 400 Wl of 0.25 M sucrose containing 0.1 M
Na2CO3 were carefully layered over them sequentially. The samples
were spun at 120 000Ug for 1.5 h at 4‡C, and the resulting upper
(containing the microsomal membranes) and lower layers were col-
lected, respectively. Both layers were treated with 10% trichloroacetic
acid, and the resulting precipitates were collected, solubilized and
subjected to SDS-PAGE. Radio-labeled HDC protein was analyzed
with a Fujix BAS 2000 Bio-Imaging Analyzer.
3. Results
3.1. Requirement of the C-terminal portion of the 74-kDa HDC
for the targeting to the particulate fraction
To investigate which portion of the peptide at the C-termi-
nal end contains the information necessary to target the HDC
to the particulate fraction, we analyzed the distribution of the
various C-terminal deletion mutants in the particulate and the
supernatant fractions of COS-7 cells by immunoblot analysis
using anti-GST-fusion HDC antibody. As a result, the 74-
kDa form of HDC (662V HDC) and the mutant 608G
HDC were entirely recovered in the particulate fraction. Sim-
ilar results were obtained in the mutants 622M HDC, 631K
HDC and 645C HDC (data not shown). In contrast, the mu-
tants 588N HDC, 578R HDC and 486C HDC (corresponding
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Fig. 2. Immunoblot analyses of the various carboxyl-terminal dele-
tion mutants expressed in COS-7 cells. Cells transfected with the
vectors indicated were fractionated into particulate (P) and superna-
tant (S) fractions as described in Section 2. Each fraction was sub-
jected to SDS-PAGE and immunoblot analysis with anti-GST-fu-
sion HDC antibody. The molecular weight marker is indicated on
the left.
Fig. 3. Immuno£uorescence study of HDC and its carboxyl-terminal deletion mutants. An immuno£uorescence study was performed with anti-
GST-fusion HDC antibody (1:500) (left) and anti-PDI antiserum (1:500) (right) and stained with secondary antibody, anti-rabbit IgG antibody
conjugated with FITC (1:200) and anti-mouse IgG antibody conjugated with rhodamine (1:150). Cells were transfected with the vectors indi-
cated. After ¢xation with 100 mM sodium phosphate, pH 7.4, containing 2% paraformaldehyde, 0.1% glutaraldehyde and 3% sucrose, cells
were permeabilized with 0.1% of Triton X-100. Thereafter cells were stained.
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to the 64-kDa and 54-kDa form of HDC, respectively), were
recovered in the supernatant fraction (Fig. 2).
3.2. Immuno£uorescent study of the intracellular localization of
the mutant HDCs
In the cells expressing 662V HDC or the mutant 608G
HDC, a reticular pattern of immuno£uorescent signal was
observed, which is similar to that of protein disul¢de isomer-
ase (PDI), a marker protein of the ER (Fig. 3). The signals of
mutants 622M, 631K or 645C HDCs were the same as those
of 662V HDC (data not shown). However, the reticular pat-
tern of signal was obscure in the cells expressing mutant
588N, 578R and 486C HDCs, where the signals were wide-
spread in the cytoplasm.
The co-localization of the 74-kDa form of HDC and PDI
was con¢rmed by confocal microscopy (Fig. 4A), but the
staining of the 54-kDa form was distinct from that of PDI
(Fig. 4B).
3.3. Intracellular localization of the GFP-fusion C-terminal
segment of HDC
To ensure the potential of the C-terminal sequence of HDC
in the translocation of a heterologous cytosolic protein to the
ER, we constructed vectors that code GFP-fusion carboxyl-
terminal segment of HDC and expressed them in COS-7 cells.
Under the conditions in which approximately 50% of GFP
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Fig. 4. Confocal microscopic observation of HDC and PDI. Cells
expressing the 74-kDa HDC (A) or 54-kDa HDC (B) were double-
stained with anti-GST fusion HDC antiserum (left) and with anti-
PDI antibody (right) as described in the legend to Fig. 3. The £uo-
rescent images were observed with a confocal microscope.
Fig. 5. Translocation of GFP by the carboxyl-terminal sequence of HDC. A: Cells transfected with pEGEP-C1, pEGFP-C1/HDC486^662, or
pEGFP-C1/HDC578^662 were fractionated into particulate and supernatant fractions as described in Section 2. Each fraction was subjected to
SDS-PAGE and immunoblot analysis with anti-GFP antibody (1:1000). The molecular weights of GFP, GFP-fusion HDC578^662 and GFP-
fusion HDC486^662 are indicated as 27, 37, and 47 kDa with the arrows, respectively. B: GFP and GFP-fusion HDC proteins were detected
by their intrinsic £uorescence (left). The counter-staining of PDI was performed (right) as described in the legend to Fig. 3. The transfection
and ¢xation of the cells was performed as described in the legend to Fig. 3. The cells expressing GFP-fusion HDC were indicated by white ar-
rows.
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protein was recovered in the supernatant fraction of COS-7
cells, neither GFP-fusion C-terminal 10-kDa nor 20-kDa seg-
ments of HDC were recovered in the supernatant fraction
(Fig. 5A). Compared with the whole cell £uorescent pattern
of GFP, the signals of both GFP-fusion C-terminal segments
demonstrated the reticular pattern corresponding to that of
PDI (Fig. 5B). These results indicate that the C-terminal re-
gion of HDC has a potential to translocate a heterologous
cytosolic protein to the ER.
3.4. Post-translational targeting of the 74-kDa form HDC
To clarify whether the targeting of HDC is a post-transla-
tional or co-translational phenomenon, we examined the as-
sociation of nascent [35S]methionine-labeled 74-kDa HDC
with canine pancreatic microsomal membranes exogenously
added to the in vitro translation assay mixture (Fig. 6A). As
a result, [35S]methionine-labeled 74-kDa HDC was associated
with the canine microsomal membranes post-translationally
(lane 4) but not co-translationally (lane 3). On the other
hand, the [35S]methionine-labeled 54-kDa HDC did not asso-
ciate with the canine microsomal membranes under any con-
ditions examined (Fig. 6B).
4. Discussion
The observations reported here provide, for the ¢rst time,
information on the mechanism of the intracellular tra⁄cking
of mouse HDC and indicate that the 74-kDa form of HDC is
targeted to the ER via its C-terminal 10-kDa portion, espe-
cially a 20 amino acid segment (residues 588N^607G).
There are several di¡erent mechanisms by which proteins
are targeted. One, which has been well characterized, is the
pathway depending on the SRP/SRP receptor [20,21]. Alter-
natively, proteins without N-terminal signal sequence are tar-
geted by a C-terminal hydrophobic domain termed an inser-
tion sequence [22]. Since HDC contains neither an N-terminal
signal sequence nor a C-terminal hydrophobic domain [14], it
is possible that the 20 amino acid segment (residues 588N^
607G) is a novel ER-targeting signal. Further, this segment
does not share any sequence homology with other proteins
except for HDC. Since its amino acid sequence is highly con-
served in HDCs from mouse, rat and human [12^14], it is
possible that the segment is responsible for the HDC-speci¢c
membrane targeting.
In a previous paper, we showed that the membrane top-
ology of the HDC in RBL-2H3 cells is similar to that of
PDI [17]. In the present study, we found that the molecular
species of HDC which coexisted with PDI is the 74-kDa form
in COS-7 cells (Figs. 3 and 4), indicating that the 74-kDa
form of HDC locates in the ER. On the other hand, the
recombinant 54-kDa HDC was recovered in the cytosol of
COS-7 cells (Figs. 2 and 4) as in the case of Sf9 cells
[15,16]. Since the recombinant 54-kDa form lacks the C-ter-
minal portion that contains the putative targeting signal, it
should be recovered in the cytosol of the expressed cells.
This result also indicates that the N-terminal 54-kDa region
does not contain the putative targeting signal.
Based on the present observation that the targeting of the
74-kDa HDC is mediated by the 20 amino acid segment (res-
idues 588N^607G), further examination is required to deter-
mine the role of this unique sequence in the association of
HDC with the ER. However, we found that a GFP-fusion
20 amino acid segment in place of the C-terminal 10-kDa
region (Fig. 6) was not targeted to the ER in COS-7 cells
(data not shown). Subsequently we speculate that the associ-
ation of the 20 amino acid segment with the ER requires other
segments in the 10-kDa region at least in the case of GFP-
fusion constructs. To con¢rm this hypothesis, proteoliposome
experiments would be useful, but at present this is di⁄cult
because we have not succeeded in the puri¢cation of the 74-
kDa HDC. It is also important to search for the targeting
factors which play a role in the translocation of HDC from
free polysomes to the ER. Very recently, we have shown that
the [35S]methionine-labeled 74-kDa HDC in RBL-2H3 cells is
susceptible to rapid degradation by the ATP-ubiquitin de-
pendent proteosome system [18]. Therefore, we hypothesize
that the targeting plays an important role in the control of
the cellular level of HDC consisting of two identical 53^55-
kDa subunits, which is formed from the precursor 74-kDa
form by post-translational processing in the lumen of the
ER [17].
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